Pharma Turns to Data Platforms to Cut Clinical Trial Costs

Drug makers are grappling with clinical trials that now cost $41 million on average. H1, a platform that helps identify and recruit trial sites and investigators more efficiently, has raised $40 million led by CVS Health Ventures. The funding reflects growing industry pressure to speed drug development without inflating costs—a persistent squeeze reshaping how new medicines reach patients.